Literature DB >> 2233759

Recognition of imidazole and histamine derivatives by monoclonal antibodies.

A Morel1, M Darmon, M Delaage.   

Abstract

The different ways of raising antibodies to histamine are reviewed. High affinity monoclonal antibodies could be raised only against derivatized histamine. Succinyl glycinamide derivatization provided the basis of an efficient radioimmunoassay. In this paper the molecular pattern and the thermodynamical properties of histamine recognition were thoroughly investigated. Only the neutral form and not the cationic form of imidazole was recognized. As expected, the ligand recognition increased, with improved structural homology to the immunogen. However, a detailed analysis revealed a zwitterionic effect whenever a carboxylic group was present on the side chain of the ligand.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2233759     DOI: 10.1016/0161-5890(90)90122-g

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

1.  Production and characterization of 22 monoclonal antibodies directed against S 20499, a new potent 5-HT1A chiral agonist: influence of the hapten structure on specificity and stereorecognition.

Authors:  P Got; E Raimbaud; C Bussey; G Caron; P A Carrupt; B Walther; A Bensussan; J M Scherrmann
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 2.  Monoclonal antibodies in hapten immunoassays.

Authors:  O N Chappey; P Sandouk; J M Scherrmann
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

Review 3.  Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.

Authors:  Robert M Sharkey; Edmund A Rossi; William J McBride; Chien-Hsing Chang; David M Goldenberg
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

Review 4.  Stereoselectivity of antibodies for the bioanalysis of chiral drugs.

Authors:  P A Got; J M Scherrmann
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

5.  Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.

Authors:  Rafke Schoffelen; Robert M Sharkey; David M Goldenberg; Gerben Franssen; William J McBride; Edmund A Rossi; Chien-Hsing Chang; Peter Laverman; Jonathan A Disselhorst; Annemarie Eek; Winette T A van der Graaf; Wim J G Oyen; Otto C Boerman
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

Review 6.  Pretargeting: taking an alternate route for localizing radionuclides.

Authors:  Robert M Sharkey; Chien-Hsing Chang; Edmund A Rossi; William J McBride; David M Goldenberg
Journal:  Tumour Biol       Date:  2012-03-07

7.  Pretargeted radioimmunotherapy for hematologic and other malignancies.

Authors:  Roland B Walter; Oliver W Press; John M Pagel
Journal:  Cancer Biother Radiopharm       Date:  2010-04       Impact factor: 3.099

8.  Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.

Authors:  Robert M Sharkey; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Journal:  Cancer Biother Radiopharm       Date:  2010-02       Impact factor: 3.099

9.  Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

Authors:  David M Goldenberg; Jean-Francois Chatal; Jacques Barbet; Otto Boerman; Robert M Sharkey
Journal:  Update Cancer Ther       Date:  2007-03

10.  Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.

Authors:  Rafke Schoffelen; Winette Ta van der Graaf; Robert M Sharkey; Gerben M Franssen; William J McBride; Chien-Hsing Chang; Peter Laverman; David M Goldenberg; Wim Jg Oyen; Otto C Boerman
Journal:  EJNMMI Res       Date:  2012-01-27       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.